SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-097070
Filing Date
2016-04-28
Accepted
2016-04-28 16:05:57
Documents
8
Period of Report
2016-06-08
Effectiveness Date
2016-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v437907_def14a.htm DEF 14A 409581
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_celator.jpg GRAPHIC 52326
4 GRAPHIC sig_mike-dougherty.jpg GRAPHIC 26049
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC v437907_proxyc-1.jpg GRAPHIC 776021
7 GRAPHIC v437907_proxyc-2.jpg GRAPHIC 934231
8 GRAPHIC v437907_proxyc-3.jpg GRAPHIC 394110
  Complete submission text file 0001144204-16-097070.txt   3417074
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36179 | Film No.: 161600039
SIC: 2834 Pharmaceutical Preparations